WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- Today, the Open Doors® 2025 Report on International Educational Exchange, the leading annual benchmark for…
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
BEIJING, Nov. 6, 2025 /PRNewswire/ -- JA Solar, a trusted global partner in green energy, signed a module supply agreement…
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…